Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by buddy2021on Jun 21, 2022 11:52am
165 Views
Post# 34771450

RE:RE:RE:and i am sure chrispi will find this to be very positive

RE:RE:RE:and i am sure chrispi will find this to be very positiveBTI is still full speed ahead on with The Blood Brain Barrier. Nothing has changed with that part of the business. BTI has recently entered BBB business relationships with world leading companies each addition bringing more eyes and attention. 

Many expected the presentation to be a full corporate business update, but it wasn't meant to be.
The content of the presentation and guests were focused on the new acquisition and how it makes BTI a more dynamic company. Yes, going to the clinic costs money. Management has shown they are creative in funding sources and avoiding unnecessary dilution.

When a decade of promotion and promise don't bring in "the big buy out” companies get put in the doghouse. Dr. R was tasked with taking BTI from a Promote the Technology company to a Prove It/ Advance the Technology company. Given that there wasn’t enough done to advance the technology since the original hand off, the task of turning the company around is not easy.

Dr. R isn't responsible for the previous decade.
Take every "real" deal/event that happened in the decade plus before Dr. R and line them up against what's been happening since she took the helm. It takes a year or more to turn the ship around and get companies engaged so pay particular attention to the quality, frequency and speed of the deal/events are happening in the last few months.






<< Previous
Bullboard Posts
Next >>